Record Information |
---|
Version | 5.0 |
---|
Status | Detected but not Quantified |
---|
Creation Date | 2021-09-11 23:13:01 UTC |
---|
Update Date | 2021-09-26 23:17:59 UTC |
---|
HMDB ID | HMDB0260058 |
---|
Secondary Accession Numbers | None |
---|
Metabolite Identification |
---|
Common Name | (8S,10S,13S,14S,17S)-17-[2-[4-(2,6-Dipyrrolidin-1-ylpyrimidin-4-yl)piperazin-1-yl]acetyl]-10,13-dimethyl-6,7,8,12,14,15,16,17-octahydrocyclopenta[a]phenanthren-3-one |
---|
Description | (8S,10S,13S,14S,17S)-17-[2-[4-(2,6-Dipyrrolidin-1-ylpyrimidin-4-yl)piperazin-1-yl]acetyl]-10,13-dimethyl-6,7,8,12,14,15,16,17-octahydrocyclopenta[a]phenanthren-3-one belongs to the class of organic compounds known as gluco/mineralocorticoids, progestogins and derivatives. These are steroids with a structure based on a hydroxylated prostane moiety. Based on a literature review very few articles have been published on (8S,10S,13S,14S,17S)-17-[2-[4-(2,6-Dipyrrolidin-1-ylpyrimidin-4-yl)piperazin-1-yl]acetyl]-10,13-dimethyl-6,7,8,12,14,15,16,17-octahydrocyclopenta[a]phenanthren-3-one. This compound has been identified in human blood as reported by (PMID: 31557052 ). (8s,10s,13s,14s,17s)-17-[2-[4-(2,6-dipyrrolidin-1-ylpyrimidin-4-yl)piperazin-1-yl]acetyl]-10,13-dimethyl-6,7,8,12,14,15,16,17-octahydrocyclopenta[a]phenanthren-3-one is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically (8S,10S,13S,14S,17S)-17-[2-[4-(2,6-Dipyrrolidin-1-ylpyrimidin-4-yl)piperazin-1-yl]acetyl]-10,13-dimethyl-6,7,8,12,14,15,16,17-octahydrocyclopenta[a]phenanthren-3-one is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
---|
Structure | CC12CC=C3C(CCC4=CC(=O)C=CC34C)C1CCC2C(=O)CN1CCN(CC1)C1=NC(=NC(=C1)N1CCCC1)N1CCCC1 InChI=1S/C37H50N6O2/c1-36-13-11-27(44)23-26(36)7-8-28-29-9-10-31(37(29,2)14-12-30(28)36)32(45)25-40-19-21-42(22-20-40)34-24-33(41-15-3-4-16-41)38-35(39-34)43-17-5-6-18-43/h11-13,23-24,28-29,31H,3-10,14-22,25H2,1-2H3 |
---|
Synonyms | Not Available |
---|
Chemical Formula | C37H50N6O2 |
---|
Average Molecular Weight | 610.847 |
---|
Monoisotopic Molecular Weight | 610.399524874 |
---|
IUPAC Name | 14-(2-{4-[2,6-bis(pyrrolidin-1-yl)pyrimidin-4-yl]piperazin-1-yl}acetyl)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-1(17),3,6-trien-5-one |
---|
Traditional Name | 14-(2-{4-[2,6-bis(pyrrolidin-1-yl)pyrimidin-4-yl]piperazin-1-yl}acetyl)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-1(17),3,6-trien-5-one |
---|
CAS Registry Number | Not Available |
---|
SMILES | CC12CC=C3C(CCC4=CC(=O)C=CC34C)C1CCC2C(=O)CN1CCN(CC1)C1=NC(=NC(=C1)N1CCCC1)N1CCCC1 |
---|
InChI Identifier | InChI=1S/C37H50N6O2/c1-36-13-11-27(44)23-26(36)7-8-28-29-9-10-31(37(29,2)14-12-30(28)36)32(45)25-40-19-21-42(22-20-40)34-24-33(41-15-3-4-16-41)38-35(39-34)43-17-5-6-18-43/h11-13,23-24,28-29,31H,3-10,14-22,25H2,1-2H3 |
---|
InChI Key | LBGLGTAQLROFTM-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as gluco/mineralocorticoids, progestogins and derivatives. These are steroids with a structure based on a hydroxylated prostane moiety. |
---|
Kingdom | Organic compounds |
---|
Super Class | Lipids and lipid-like molecules |
---|
Class | Steroids and steroid derivatives |
---|
Sub Class | Pregnane steroids |
---|
Direct Parent | Gluco/mineralocorticoids, progestogins and derivatives |
---|
Alternative Parents | |
---|
Substituents | - Progestogin-skeleton
- 20-oxosteroid
- 3-oxo-delta-1,4-steroid
- 3-oxosteroid
- Oxosteroid
- Delta-1,4-steroid
- N-arylpiperazine
- Dialkylarylamine
- Aminopyrimidine
- N-alkylpiperazine
- 1,4-diazinane
- Piperazine
- Pyrimidine
- Imidolactam
- Pyrrolidine
- Alpha-aminoketone
- Heteroaromatic compound
- Tertiary amine
- Cyclic ketone
- Tertiary aliphatic amine
- Ketone
- Azacycle
- Organoheterocyclic compound
- Organic oxygen compound
- Hydrocarbon derivative
- Organic nitrogen compound
- Organic oxide
- Carbonyl group
- Organopnictogen compound
- Organonitrogen compound
- Organooxygen compound
- Amine
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | | Show more...
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedMetabolite | SMILES | Kovats RI Value | Column Type | Reference |
---|
(8S,10S,13S,14S,17S)-17-[2-[4-(2,6-Dipyrrolidin-1-ylpyrimidin-4-yl)piperazin-1-yl]acetyl]-10,13-dimethyl-6,7,8,12,14,15,16,17-octahydrocyclopenta[a]phenanthren-3-one | CC12CC=C3C(CCC4=CC(=O)C=CC34C)C1CCC2C(=O)CN1CCN(CC1)C1=NC(=NC(=C1)N1CCCC1)N1CCCC1 | 4423.6 | Standard polar | 33892256 | (8S,10S,13S,14S,17S)-17-[2-[4-(2,6-Dipyrrolidin-1-ylpyrimidin-4-yl)piperazin-1-yl]acetyl]-10,13-dimethyl-6,7,8,12,14,15,16,17-octahydrocyclopenta[a]phenanthren-3-one | CC12CC=C3C(CCC4=CC(=O)C=CC34C)C1CCC2C(=O)CN1CCN(CC1)C1=NC(=NC(=C1)N1CCCC1)N1CCCC1 | 5389.6 | Standard non polar | 33892256 | (8S,10S,13S,14S,17S)-17-[2-[4-(2,6-Dipyrrolidin-1-ylpyrimidin-4-yl)piperazin-1-yl]acetyl]-10,13-dimethyl-6,7,8,12,14,15,16,17-octahydrocyclopenta[a]phenanthren-3-one | CC12CC=C3C(CCC4=CC(=O)C=CC34C)C1CCC2C(=O)CN1CCN(CC1)C1=NC(=NC(=C1)N1CCCC1)N1CCCC1 | 5767.6 | Semi standard non polar | 33892256 |
DerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
(8S,10S,13S,14S,17S)-17-[2-[4-(2,6-Dipyrrolidin-1-ylpyrimidin-4-yl)piperazin-1-yl]acetyl]-10,13-dimethyl-6,7,8,12,14,15,16,17-octahydrocyclopenta[a]phenanthren-3-one,1TMS,isomer #1 | CC12C=CC(=O)C=C1CCC1C2=CCC2(C)C(=C(CN3CCN(C4=CC(N5CCCC5)=NC(N5CCCC5)=N4)CC3)O[Si](C)(C)C)CCC12 | 5412.8 | Semi standard non polar | 33892256 | (8S,10S,13S,14S,17S)-17-[2-[4-(2,6-Dipyrrolidin-1-ylpyrimidin-4-yl)piperazin-1-yl]acetyl]-10,13-dimethyl-6,7,8,12,14,15,16,17-octahydrocyclopenta[a]phenanthren-3-one,1TMS,isomer #1 | CC12C=CC(=O)C=C1CCC1C2=CCC2(C)C(=C(CN3CCN(C4=CC(N5CCCC5)=NC(N5CCCC5)=N4)CC3)O[Si](C)(C)C)CCC12 | 5177.1 | Standard non polar | 33892256 | (8S,10S,13S,14S,17S)-17-[2-[4-(2,6-Dipyrrolidin-1-ylpyrimidin-4-yl)piperazin-1-yl]acetyl]-10,13-dimethyl-6,7,8,12,14,15,16,17-octahydrocyclopenta[a]phenanthren-3-one,1TMS,isomer #1 | CC12C=CC(=O)C=C1CCC1C2=CCC2(C)C(=C(CN3CCN(C4=CC(N5CCCC5)=NC(N5CCCC5)=N4)CC3)O[Si](C)(C)C)CCC12 | 6573.1 | Standard polar | 33892256 | (8S,10S,13S,14S,17S)-17-[2-[4-(2,6-Dipyrrolidin-1-ylpyrimidin-4-yl)piperazin-1-yl]acetyl]-10,13-dimethyl-6,7,8,12,14,15,16,17-octahydrocyclopenta[a]phenanthren-3-one,1TMS,isomer #2 | CC12C=CC(=O)C=C1CCC1C2=CCC2(C)C(C(=CN3CCN(C4=CC(N5CCCC5)=NC(N5CCCC5)=N4)CC3)O[Si](C)(C)C)CCC12 | 5537.2 | Semi standard non polar | 33892256 | (8S,10S,13S,14S,17S)-17-[2-[4-(2,6-Dipyrrolidin-1-ylpyrimidin-4-yl)piperazin-1-yl]acetyl]-10,13-dimethyl-6,7,8,12,14,15,16,17-octahydrocyclopenta[a]phenanthren-3-one,1TMS,isomer #2 | CC12C=CC(=O)C=C1CCC1C2=CCC2(C)C(C(=CN3CCN(C4=CC(N5CCCC5)=NC(N5CCCC5)=N4)CC3)O[Si](C)(C)C)CCC12 | 5210.6 | Standard non polar | 33892256 | (8S,10S,13S,14S,17S)-17-[2-[4-(2,6-Dipyrrolidin-1-ylpyrimidin-4-yl)piperazin-1-yl]acetyl]-10,13-dimethyl-6,7,8,12,14,15,16,17-octahydrocyclopenta[a]phenanthren-3-one,1TMS,isomer #2 | CC12C=CC(=O)C=C1CCC1C2=CCC2(C)C(C(=CN3CCN(C4=CC(N5CCCC5)=NC(N5CCCC5)=N4)CC3)O[Si](C)(C)C)CCC12 | 6541.3 | Standard polar | 33892256 | (8S,10S,13S,14S,17S)-17-[2-[4-(2,6-Dipyrrolidin-1-ylpyrimidin-4-yl)piperazin-1-yl]acetyl]-10,13-dimethyl-6,7,8,12,14,15,16,17-octahydrocyclopenta[a]phenanthren-3-one,1TBDMS,isomer #1 | CC12C=CC(=O)C=C1CCC1C2=CCC2(C)C(=C(CN3CCN(C4=CC(N5CCCC5)=NC(N5CCCC5)=N4)CC3)O[Si](C)(C)C(C)(C)C)CCC12 | 5663.5 | Semi standard non polar | 33892256 | (8S,10S,13S,14S,17S)-17-[2-[4-(2,6-Dipyrrolidin-1-ylpyrimidin-4-yl)piperazin-1-yl]acetyl]-10,13-dimethyl-6,7,8,12,14,15,16,17-octahydrocyclopenta[a]phenanthren-3-one,1TBDMS,isomer #1 | CC12C=CC(=O)C=C1CCC1C2=CCC2(C)C(=C(CN3CCN(C4=CC(N5CCCC5)=NC(N5CCCC5)=N4)CC3)O[Si](C)(C)C(C)(C)C)CCC12 | 5423.8 | Standard non polar | 33892256 | (8S,10S,13S,14S,17S)-17-[2-[4-(2,6-Dipyrrolidin-1-ylpyrimidin-4-yl)piperazin-1-yl]acetyl]-10,13-dimethyl-6,7,8,12,14,15,16,17-octahydrocyclopenta[a]phenanthren-3-one,1TBDMS,isomer #1 | CC12C=CC(=O)C=C1CCC1C2=CCC2(C)C(=C(CN3CCN(C4=CC(N5CCCC5)=NC(N5CCCC5)=N4)CC3)O[Si](C)(C)C(C)(C)C)CCC12 | 6680.4 | Standard polar | 33892256 | (8S,10S,13S,14S,17S)-17-[2-[4-(2,6-Dipyrrolidin-1-ylpyrimidin-4-yl)piperazin-1-yl]acetyl]-10,13-dimethyl-6,7,8,12,14,15,16,17-octahydrocyclopenta[a]phenanthren-3-one,1TBDMS,isomer #2 | CC12C=CC(=O)C=C1CCC1C2=CCC2(C)C(C(=CN3CCN(C4=CC(N5CCCC5)=NC(N5CCCC5)=N4)CC3)O[Si](C)(C)C(C)(C)C)CCC12 | 5776.9 | Semi standard non polar | 33892256 | (8S,10S,13S,14S,17S)-17-[2-[4-(2,6-Dipyrrolidin-1-ylpyrimidin-4-yl)piperazin-1-yl]acetyl]-10,13-dimethyl-6,7,8,12,14,15,16,17-octahydrocyclopenta[a]phenanthren-3-one,1TBDMS,isomer #2 | CC12C=CC(=O)C=C1CCC1C2=CCC2(C)C(C(=CN3CCN(C4=CC(N5CCCC5)=NC(N5CCCC5)=N4)CC3)O[Si](C)(C)C(C)(C)C)CCC12 | 5428.4 | Standard non polar | 33892256 | (8S,10S,13S,14S,17S)-17-[2-[4-(2,6-Dipyrrolidin-1-ylpyrimidin-4-yl)piperazin-1-yl]acetyl]-10,13-dimethyl-6,7,8,12,14,15,16,17-octahydrocyclopenta[a]phenanthren-3-one,1TBDMS,isomer #2 | CC12C=CC(=O)C=C1CCC1C2=CCC2(C)C(C(=CN3CCN(C4=CC(N5CCCC5)=NC(N5CCCC5)=N4)CC3)O[Si](C)(C)C(C)(C)C)CCC12 | 6652.1 | Standard polar | 33892256 |
| Show more...
---|